Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Kindly MD ( (NAKA) ) just unveiled an update.
On December 17, 2025, KindlyMD held its annual stockholders’ meeting virtually, with approximately 60.84% of outstanding shares represented, and shareholders elected two Class I directors for three-year terms, approved the company’s conversion from a Utah to a Delaware corporation, ratified Sadler, Gibb & Associates, LLC as independent auditor for fiscal 2025, and authorized potential adjournment of the meeting if additional votes were needed. On December 18, 2025, the board approved a share repurchase program of up to $10 million of common stock and entered into a Rule 10b-18 repurchase plan with TD Securities Inc., a move intended to enhance capital allocation flexibility and signaling management’s confidence in the company’s long-term value and Bitcoin-focused treasury strategy, with potential implications for shareholder returns and capital structure.
The most recent analyst rating on (NAKA) stock is a Buy with a $1.50 price target. To see the full list of analyst forecasts on Kindly MD stock, see the NAKA Stock Forecast page.
Spark’s Take on NAKA Stock
According to Spark, TipRanks’ AI Analyst, NAKA is a Underperform.
The overall stock score of 38 reflects significant financial and technical challenges. The company’s financial performance is weak, with declining revenues and profitability issues. Technical analysis indicates bearish momentum, and valuation metrics are unattractive due to negative earnings. These factors collectively contribute to a low stock score.
To see Spark’s full report on NAKA stock, click here.
More about Kindly MD
KindlyMD, Inc. (NASDAQ: NAKA) is a patient-first healthcare and data company focused on value-based, patient-centered medical services that leverage data analysis to reduce opioid use, improve health outcomes, and guide the use of alternative medicines. Formed in 2019 and based in Salt Lake City, the company expanded its strategic scope in August 2025 by merging with Bitcoin-native holding company Nakamoto Holdings Inc., creating a diversified platform that combines integrated healthcare services with Bitcoin treasury management and a broader Bitcoin-focused capital markets strategy.
Average Trading Volume: 23,440,310
Technical Sentiment Signal: Sell
Learn more about NAKA stock on TipRanks’ Stock Analysis page.